Immuno-Monitoring
ImmunAlp PDF Print E-mail

IMMUNALP_FINAL_blueOverview

The process of identifying compounds with toxic properties in the early stages of drug development is an essential step in avoiding wasting valuable time and money on unsuitable and usafe drug candidates.

The ImmunAlp website is currently under construction. Please refer to this webpage until further notice.

Please take part in our survey by clicking here and help us ensure we meet the demands of Industry in the field of immunotoxicity.
Read more...
 


TECHNOLOGY FOCUS

TESTIMONIALS

“We are convinced of the usefulness of BGENE’s customized sequence modification service on bacterial genomes or vectors without scarring"  European biotech company
Read more...